New antigens involved in membranous nephropathy beyond phospholipase A2 receptor

Table 1 Clinical findings in Semaphorin 3B-associated membranous nephropathy[8,28,29]

Case	Age (yr)/sex	UP (g/24)	Serum CR (mg/dL)	Remission	Serum CR/UP/24 h
1	41/F	7.9	0.74	Spontaneous	0.6/no proteinuria (16 mo)
2	26/F	6.2	0.4	Spontaneous	0.43/400 mg (18 mo)
3	2/M	5	0.5	Immunosuppressive	0.35/150 mg (24 mo)
4	40/F	17.3	0.9	Immunosuppressive	0.6/no proteinuria (10 yr)
5	19 mo/M	0.4	0.7	Immunosuppressive	0.9/400 mg (18 mo)
6	2/F	UP/CR ratio 6.81	0.21	Immunosuppressive	UP/CR ratio 0.23 (13 mo)
7	17/M	UP/CR ratio 0.78	0.6	Immunosuppressive	UP/CR ratio 0.1 (19 mo)
8	9 mo/M	UP/CR ratio 0.94	0.45	Immunosuppressive	UP/CR ratio 0.09 /14 yr)
9	2/M	UP/CR ratio 1.95	0.13	Immunosuppressive	UP/CR ratio 0.12 (5 yr)
10	14/M	3	0.64	Lost to follow up	n/a
11	16/M	12	0.83	Immunosuppressive	Dialysis

F: Female; M: Male; UP: Urinary protein; CR: Creatinine.